Paper57788
The sensitivity to cytotoxic agents of the EMT6 tumor in vivo. Comparative response of lung nodules in rapid expotential growth and of the solid flank tumour.
Twentyman PR and 1 other. Br J Cancer, 1976. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. The sensitivity to cytotoxic agents of the EMT6 tumor in vivo. Comparative response of lung nodules in rapid expotential growth and of the solid flank tumour. Papers, record 57788. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/57788
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The sensitivity to cytotoxic agents of the EMT6 tumor in vivo. Comparative response of lung nodules in rapid expotential growth and of the solid flank tumour.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Lung Neoplasms | Major topic |
| Neoplasms, Experimental | Major topic |
| Animals | |
| Bleomycin | |
| Carmustine | |
| Cell Line | |
| Cell Survival | |
| Cyclophosphamide | |
| Dose-Response Relationship, Drug | |
| Doxorubicin | |
| Lomustine | |
| Male | |
| Mice | |
| Mice, Inbred BALB C | |
| Time Factors |
Source PubMed
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1120304 | The response of hypoxic B16 melanoma cells to in vivo treatment with chemotherapeutic agents. | Cancer Res | 1975 | https://conductscience.org/library/papers/1120304 | PubMed |
| 2 | 1131813 | In vitro evaluation of in vivo brain tumor chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea. | Cancer Res | 1975 | https://conductscience.org/library/papers/1131813 | PubMed |
| 3 | 1156523 | Changes in sensitivity to cytotoxic agents occurring during the life history of monolayer cultures of a mouse tumour cell line. | Br J Cancer | 1975 | https://conductscience.org/library/papers/1156523 | PubMed |
| 4 | 1169108 | Stem-cell survival and tumor control in the Lewis lung carcinoma. | Cancer Res | 1975 | https://conductscience.org/library/papers/1169108 | PubMed |
| 5 | 4125097 | The sensitivity to bleomycin of spleen colony forming units in the mouse. | Br J Cancer | 1973 | https://conductscience.org/library/papers/4125097 | PubMed |
| 6 | 4126375 | Response of a murine solid tumor to in vivo combined chemotherapy and irradiation. | Radiology | 1973 | https://conductscience.org/library/papers/4126375 | PubMed |
| 7 | 4128424 | Cell survival and repair of plateau-phase cultures after chemotherapy--relevance to tumor therapy and to the in vitro screening of new agents. | Cancer Chemother Rep | 1973 | https://conductscience.org/library/papers/4128424 | PubMed |
| 8 | 4135685 | Responses of cycling and noncycling cells to 1,3-bis(2-chloroethyl)-1-nitrosourea and to bleomycin. | Cancer Res | 1974 | https://conductscience.org/library/papers/4135685 | PubMed |
| 9 | 4143273 | The sensitivity to bleomycin of a solid mouse tumour at different stages of growth. | Br J Cancer | 1974 | https://conductscience.org/library/papers/4143273 | PubMed |
| 10 | 4578656 | Differential lethal effect of cytotoxic agents on proliferating and nonproliferating lymphoid cells. | Cancer Res | 1973 | https://conductscience.org/library/papers/4578656 | PubMed |
| 11 | 4607700 | Are cell kinetic data relevant for the design of tumour chemotherapy schedules? | Cell Tissue Kinet | 1974 | https://conductscience.org/library/papers/4607700 | PubMed |
| 12 | 4633910 | Tumor chemotherapy: efficacy dependent on mode of growth. | J Natl Cancer Inst | 1973 | https://conductscience.org/library/papers/4633910 | PubMed |
| 13 | 4646827 | Cell proliferation and the action of cytotoxic agents on haemopoietic tissue. | Br J Haematol | 1972 | https://conductscience.org/library/papers/4646827 | PubMed |
| 14 | 4647494 | Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. | J Natl Cancer Inst | 1972 | https://conductscience.org/library/papers/4647494 | PubMed |
| 15 | 4678087 | Plateau-phase cultures of mammalian cells: an in vitro model for human cancer. | Curr Top Radiat Res Q | 1972 | https://conductscience.org/library/papers/4678087 | PubMed |
| 16 | 47265 | Studies on recovery from chemically induced damage in mammalian cells. | Cancer Res | 1975 | https://conductscience.org/library/papers/47265 | PubMed |
| 17 | 48253 | Thermochemotherapy: synergism between hyperthermia (42-43 degrees) and adriamycin (of bleomycin) in mammalian cell inactivation. | Proc Natl Acad Sci U S A | 1975 | https://conductscience.org/library/papers/48253 | PubMed |
| 18 | 4858112 | Survival responses of dividing and nondividing mammalian cells after treatment with hydroxyurea, arabinosylcytosine, or adriamycin. | Cancer Res | 1974 | https://conductscience.org/library/papers/4858112 | PubMed |
| 19 | 55271 | Studies of "potentially lethal damage" in EMT6 mouse tumour cells treated with bleomycin either in vitro or in vivo. | Br J Cancer | 1975 | https://conductscience.org/library/papers/55271 | PubMed |
| 20 | 5799415 | The influence of the anatomic locationof a tumor on its susceptibility to chemotherapy. | Cancer Chemother Rep | 1969 | https://conductscience.org/library/papers/5799415 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 23536304 | Boron neutron capture therapy demonstrated in mice bearing EMT6 tumors following selective delivery of boron by rationally designed liposomes. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23536304 | PubMed |
| 7073936 | In vivo tumour-cell proliferation after adriamycin treatment. | Br J Cancer | 1982 | https://conductscience.org/library/papers/7073936 | PubMed |
| 6691899 | A bioassay for cyclophosphamide in blood, lung and tumour. | Br J Cancer | 1984 | https://conductscience.org/library/papers/6691899 | PubMed |
| 911660 | Metastasis of a transplantable mammary tumour in rats treated with cyclophosphamide and/or irradiation. | Br J Cancer | 1977 | https://conductscience.org/library/papers/911660 | PubMed |
| 889677 | Influence of tumour size on hypoxic fraction and therapeutic sensitivity of Lewis lung tumour. | Br J Cancer | 1977 | https://conductscience.org/library/papers/889677 | PubMed |
| 836758 | Sensitivity to cytotoxic agents of the EMT6 tumour in vivo: tumour volume versus in vitro plating. 1. Cyclophosphamide. | Br J Cancer | 1977 | https://conductscience.org/library/papers/836758 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/57788
GET https://conductscience.org/api/papers/v1/57788/authors